Pharmacokinetics of doxylamine, a component of bendectin®, in the rhesus monkey

Add time:07/25/2019    Source:sciencedirect.com

The elimination of doxylamine and metabolites was determined after iv administration of [14C]doxylamine succinate at 0.7 and 13.3 mg/kg to the adult female rhesus monkey. Although the total recovery of radioactivity was the same for the low-and high-dose studies (90.2%), the rate of plasma elimination of doxylamine and its demethylated metabolite (desmethyldoxylamine) was slower for the high dose group. The 24 hr urinary excretion of doxylamine metabolites, desmethyl- and didesmethyldoxylamine, was significantly increased and the polar doxylamine metabolites were significantly decreased as the iv doxylamine succinate dose was increased. The plasma elimination of gas chromatograph (GC)-detected doxylamine was determined after oral administration of Bendectin® (doxylamine succinate and pyridoxine hydrochloride) at 7, 13.3, and 27 mg/kg to adult female rhesus monkeys. As the dose increased, the clearance of doxylamine decreased. A statistically evaluated fit of the oral data to a single-compartment, parallel first-order elimination model and a single-compartment, parallel first- and second-order (Michaelis-Menten) elimination model indicated that the more complex model containing the second-order process was most consistent with the observed elimination data.

We also recommend Trading Suppliers and Manufacturers of DesMethyl DoxylaMine (cas 1221-70-1). Pls Click Website Link as below: cas 1221-70-1 suppliers

Prev:Rapid identification of trimethyl and Triethyl Amine (cas 1221-44-8)s using sulphonic acidic ionic liquids: A time-of-flight secondary ion mass spectrometry study of fragmentation reactions
Next:Vaporization enthalpy and vapor pressure of (−) Ambroxide and GALAXOLIDE (cas 1222-05-5) by correlation gas chromatography)